Albumin Use in AKI: Generally Not Recommended
In most patients with acute kidney injury, albumin should NOT be administered for volume expansion or to treat AKI itself—use isotonic crystalloids instead. 1
General AKI Population: Avoid Albumin
The KDIGO guidelines explicitly recommend using isotonic crystalloids rather than colloids (including albumin) as initial management for expansion of intravascular volume in patients at risk for AKI or with established AKI (Grade 2B recommendation). 1 This applies broadly to most AKI scenarios you'll encounter.
Key Reasoning:
- Albumin offers no mortality benefit in general AKI populations
- Crystalloids are equally effective for volume resuscitation
- Albumin is significantly more expensive
- Potential risks include fluid overload and pulmonary edema 2
Important caveat: Starch-containing fluids should be completely avoided in AKI patients due to demonstrated harm. 1
Specific Exceptions Where Albumin IS Indicated
Despite the general recommendation against albumin, there are specific clinical contexts where albumin administration is appropriate and beneficial:
1. Cirrhosis with Large-Volume Paracentesis
Albumin should be administered at 8 g/L of ascites removed when >5L is drained. 3, 4 This prevents post-paracentesis circulatory dysfunction and reduces AKI risk (21% AKI rate without albumin vs 0% with albumin in one RCT). 4
2. Spontaneous Bacterial Peritonitis (SBP) in Cirrhosis
Give albumin 1.5 g/kg on day 1 and 1.0 g/kg on day 3 in addition to antibiotics. 4 This reduces AKI from 33% to 10% and mortality from 29% to 10%. 4 Patients with baseline creatinine >1.0 mg/dL or bilirubin >4 mg/dL benefit most.
3. Hepatorenal Syndrome-AKI
Albumin (1 g/kg/day up to 100 g/day for at least 2 days) is part of the diagnostic criteria and treatment protocol for hepatorenal syndrome. 1, 5 Recent evidence supports continuing albumin for 48 hours rather than stopping at 24 hours, as significant responses occur between 24-48 hours. 5
4. Traumatic Brain Injury: CONTRAINDICATED
Do NOT use albumin in patients with traumatic brain injury and AKI—it has been associated with harm. 1
Metabolic Acidosis Consideration
Your question mentions metabolic acidosis with AKI. Albumin does not treat metabolic acidosis and is not indicated for this purpose. 6
- For severe metabolic acidemia (pH ≤7.20) with AKI, sodium bicarbonate infusion does not improve mortality but may reduce need for kidney replacement therapy 7
- Albumin infusion can actually cause mild metabolic acidosis due to its high chloride content (150 mmol/L) 8
Practical Algorithm
For a patient with AKI and metabolic acidosis:
Is there cirrhosis with complications?
- Large-volume paracentesis planned? → Give albumin (8 g/L removed)
- SBP diagnosed? → Give albumin (1.5 g/kg day 1.0 g/kg day 3)
- Hepatorenal syndrome? → Give albumin (1 g/kg/day up to 100 g)
Is there traumatic brain injury?
- Yes? → Absolutely avoid albumin
All other AKI scenarios?
- Use isotonic crystalloids (preferably balanced crystalloids over 0.9% saline)
- Do NOT give albumin for volume expansion or to "treat" AKI
- Do NOT give albumin to correct hypoalbuminemia in AKI 6
Common Pitfalls to Avoid
- Don't use albumin to correct low serum albumin levels in AKI—this is not justified and offers no benefit 6
- Don't extrapolate cirrhosis data to general AKI—the benefits of albumin in SBP/paracentesis do NOT apply to other infections or AKI etiologies 4
- Don't use albumin for sepsis-related AKI outside of cirrhosis—three RCTs showed no benefit and increased pulmonary edema risk 4
- Monitor for fluid overload—albumin can cause pulmonary edema, especially in oliguric AKI patients 2